Furthermore, ligands (such as ULBPs and MICA) of NK cells activating receptor NKG2D, which are essential for NK cell lytic activity, are downregulated in gliomas and hepatocellular carcinoma (HCC) cells via DNA methylation and histone methylation, respectively [76,77]. The gene discussed is KLRK1; the disease is glioma.